Sign in

CIK 0001674416 · Large accelerated filer

CRISPR Therapeutics AG

Sign in to watch
Ticker
CRSP
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
Switzerland
Entity type
operating
EIN
473173478
Phone
6173154600
Business address
BAARERSTRASSE 14, ZUG, Switzerland
Former names
CRISPR Therapeutics AG
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$4,881,673
in 7 filings, $1.5M under 10b5-1 plans

Net −$4,881,673. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Kulkarni Samarth −$2.6M Chief Executive Officer sold 14% of stake
  2. KASINGER JAMES R. −$797K General Counsel and Secretary sold 12% of stake
  3. Behbahani Ali −$781K Director sold 45% of stake
  4. George Simeon −$720K Director sold 48% of stake

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2023-03-10 KASINGER JAMES R. General Counsel and Secretary Grant or award · Restricted Stock Units +22,000 22,000
2023-03-10 Morrow Phuong Khanh Chief Medical Officer Grant or award · Stock Option (Right to Buy) +44,620 44,620
2023-03-10 Morrow Phuong Khanh Chief Medical Officer Grant or award · Restricted Stock Units +22,000 22,000
2023-02-27 Kulkarni Samarth Chief Executive Officer Option exercise +25,000 $19.12 $478K 400,988
2023-02-27 Kulkarni Samarth Chief Executive Officer Sale −10,180 $47.71 $486K 390,808
2023-02-27 Kulkarni Samarth Chief Executive Officer Sale −13,720 $48.57 $666K 377,088
2023-02-27 Kulkarni Samarth Chief Executive Officer Sale −1,100 $49.20 $54K 375,988
2023-02-27 Kulkarni Samarth Chief Executive Officer Option exercise · Stock Option (Right to Buy) −25,000 154,582
2023-02-21 Smith Brendan Chief Financial Officer Shares withheld for taxes −1,392 $48.26 $67K 5,072
2023-02-21 Kulkarni Samarth Chief Executive Officer Shares withheld for taxes −6,373 $48.26 $308K 375,988
2023-02-21 KASINGER JAMES R. General Counsel and Secretary Shares withheld for taxes −1,950 $48.26 $94K 52,066
2023-02-18 Smith Brendan Chief Financial Officer Option exercise +3,825 6,464
2023-02-18 Smith Brendan Chief Financial Officer Option exercise · Restricted Stock Units −3,825 11,475
2023-02-18 Kulkarni Samarth Chief Executive Officer Option exercise +13,250 382,361
2023-02-18 Kulkarni Samarth Chief Executive Officer Option exercise · Restricted Stock Units −13,250 39,750
2023-02-18 KASINGER JAMES R. General Counsel and Secretary Option exercise +3,825 54,016
2023-02-18 KASINGER JAMES R. General Counsel and Secretary Option exercise · Restricted Stock Units −3,825 11,475
2023-01-27 Kulkarni Samarth Chief Executive Officer Option exercise +25,000 $19.12 $478K 394,111
2023-01-27 Kulkarni Samarth Chief Executive Officer Sale −1,800 $50.60 $91K 392,311
2023-01-27 Kulkarni Samarth Chief Executive Officer Sale −23,200 $51.54 $1.2M 369,111

Page 18 of 46 · 910 trades